Marty Makary

1 week ago | washingtonpost.com | Marty Makary

How we plan to cut FDA drug approval time by months (washingtonpost.com) How we plan to cut FDA drug approval time by months By Marty Makary 2025061918574500 For more than a century, the U.S. Food and Drug Administration has been a global leader in advancing medical cures, but in recent years, its regulatory framework has become an obstacle to innovation.

1 week ago | healthimpactnews.com | Brian Shilhavy |Marty Makary

by Brian ShilhavyEditor, Health Impact NewsWhile HHS Secretary Kennedy has promised more rigorous study of drugs using higher standards and returning to the “Gold Standard of Medical Research” before they are approved, his FDA is doing the exact opposite.

1 month ago | wacotrib.com | Marty Makary

Casey Means, a Stanford-trained physician and wellness influencer nominated by President Donald Trump for surgeon general, is convinced the U.S. is experiencing an epidemic of metabolic dysfunction — a crisis silently unfolding inside the cells of millions of Americans. One solution, she says, is giving people a close-up view of that crisis. Coincidentally, a company she co-founded, Levels, sells a system that allows people to continuously track their blood glucose levels in real time.

1 month ago | northcentralpa.com | Marty Makary

Washington, D.C. — The FDA is continuing to see reports of adverse events following use of tianeptine-containing products. Tianeptine is not approved by FDA for any medical use and exposure may result in serious harm, including death. Side effects associated with tianeptine use include agitation, confusion, breathing difficulties, and death, among others. Tianeptine is frequently available at convenience stores, gas stations, vape shops, and online retailers.

Jan 4, 2025 | wired.jp | Marty Makary

世界中のビジョナリーや起業家、ビッグシンカーがキーワードを掲げ、2025年の最重要パラダイムを読み解く恒例の総力特集「THE WORLD IN 2025」。ジョンズ・ホプキンズ大学医学部教授のマーティー・マカリーは、患者の症状に合わせて適切な善玉菌が処方されるような医学の進展に期待を寄せている。 医学界でマイクロバイオーム（腸内に生息する無数の微生物叢）が注目されている。マイクロバイオームが消化を助け、免疫系を鍛え、エストロゲンを調節し、セロトニンの生成にも影響していることは以前から知られていた。だが最新の研究で、若年者の学習障害や慢性疾患、さらにはがんの発生にも関係している可能性が示唆されたのだ。 抗生物質は、マイクロバイオームに変化をもたらすことで知られている。米ミネソタ州の総合病院メイヨー・クリニックが14,572人の子どもを対象とした調査によると、抗生物質を服用した子どもは、ぜんそくや肥満、セリアック病、注意欠陥・多動性障害（ADHD）の発生率が上昇したという。さらに驚くべきは、抗生物質の服用を増やすほど、子どもがこれらの疾患を発症するリスクは高まるということだ。...